Ultragenyx Pharmaceutical Eliminating ~20% Employees
Benzinga Newsdesk 1 day ago
News
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced it is
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced it is reducing headcount by approximately 20%, resulting in a revised workforce of approximately 1,000 employees.